# Anika Therapeutics, Inc.: Form DEF 14A, filed Jun 11, 2024

- Company: [Anika Therapeutics, Inc.](/companies/anik.md) (CIK 898437)
- Form: DEF 14A
- Filed: 2024-06-11
- Accepted by EDGAR: Jun 11, 2024, 17:05 ET
- Period: 2024-07-09
- Accession: 0001193125-24-159219
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/898437/000119312524159219/d692662ddef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/898437/000119312524159219/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/898437/000119312524159219/d692662ddef14a.htm

Filed Jun 11, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-159219. Last ingested by Listed: Nov 6, 2026, 15:05 ET. No prices; not investment advice.
